213
Participants
Start Date
October 28, 2014
Primary Completion Date
April 4, 2016
Study Completion Date
April 4, 2016
AZD7624 1.0 mg
Inhaled AZD7624 solution, 11 mg/mL
Placebo
Inhaled placebo solution
Research Site, Ciudad Autónoma de Bs. As.
Research Site, Johannesburg
Research Site, Johannesburg
Research Site, Parktown West
Research Site, San Miguel de Tucumán
Research Site, eManzimtoti
Research Site, Mount Edgecombe
Research Site, Cape Town
Research Site, Larchmont
Research Site, Erie
Research Site, Baltimore
Research Site, Charlotte
Research Site, Wilmington
Research Site, Gaffney
Research Site, Greenville
Research Site, Rock Hill
Research Site, Atlanta
Research Site, Blue Ridge
Research Site, Hialeah
Research Site, Pembroke Pines
Research Site, Miami
Research Site, Akron
Research Site, Dayton
Research Site, St Louis
Research Site, Kingwood
Research Site, Denver
Research Site, Los Angeles
Research Site, Torrance
Research Site, Talca
Research Site, Talcahuano
Research Site, Santiago
Research Site, Santiago
Research Site, Buenos Aires
Research Site, CABA
Research Site, Quilmes
Research Site, Assen
Research Site, Heerlen
Research Site, Nijmegen
Research Site, Zutphen
Research Site, Lima
Research Site, Lima
Lead Sponsor
AstraZeneca
INDUSTRY